Peptide Library

FDA-approved

Digestive & weight

Terlipressin

Evidence

FDA approved

Class

Vasopressin analog

/

Terlipressin

KEY TAKEAWAY

Terlipressin is a synthetic analog of vasopressin that the body converts to its active form. It is sold as Terlivaz. The FDA approved terlipressin (Terlivaz) in 2022 to improve kidney function in adults with hepatorenal syndrome.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Vasopressin analog

Approved for

Hepatorenal syndrome with rapidly declining kidney function

Key fact

The FDA approved terlipressin (Terlivaz) in 2022 to improve kidney function in adults with hepatorenal syndrome.

Route

Intravenous injection

Evidence strength

FDA approved

What it is

What it is

Terlipressin is a synthetic analog of vasopressin that the body converts to its active form. It is sold as Terlivaz.

How it works

How it works

It narrows blood vessels in the gut, which redirects blood flow toward the kidneys in people with advanced liver disease.

Regulatory status

Regulatory status

The FDA approved terlipressin (Terlivaz) in 2022 to improve kidney function in adults with hepatorenal syndrome.

What it is used for

What it is used for

Hepatorenal syndrome with rapidly declining kidney function.

Side effects and risks

Side effects and risks

The label carries a boxed warning for serious or fatal respiratory failure, so people with low oxygen or fluid overload are at higher risk.

Citations

Citations

U.S. FDA prescribing information for Terlipressin. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo